⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

TRVI

Trevi Therapeutics, Inc.

Healthcare · Biotechnology

12.61USD

-0.3300 (-2.55%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TRVI.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 12.61
P/E—
Dvd Ind Yld0.0%
P/B5.59
P/S—
Curr EV/T12M EBITDA-24.9
Mkt Cap (USD)1.8B
Curr EV (USD)1.5B
2)

Per Share Data

EPS T12M-0.34
DPS—
Bk Val Per Sh2.26
Rev/Sh—
Cash/Sh2.24
Curr Shares Out142.5M
FCF/Sh-0.34
3)

Cash Flow Analysis

P/CF-34.1
Curr P/FCF-34.0
CF/NI1.0
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales—
Eff Interest Rate0.2%
4)

Growth Potential

Dil EPS 1Y Gr31.9%
Cap 1Y Gr83.9%
BPS 1Y Gr39.2%
R&D To Sales—
Retention Rate—
Rev 1Y Gr—
FCF 1Y Gr-10.0%
Assets 1Y Gr74.4%
5)

Profitability

EBITDA-0.1B
EBIT-0.1B
Operating Margin0.0%
Pretax Margin—
Net Margin0.0%
ROA-19.0%
ROE-19.7%
ROC-18.5%
Asset Turnover—
6)

Structure

Current Ratio37.28
Quick Ratio36.68
Debt/Assets0.2%
Debt/Com Eq0.2%
Net Debt/EBITDA0.90
Tot Debt/Capital0.2%
Gross Margin0.0%
EBIT/Int Exp-59,557.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.